Recombinant Galactosylceramidase (GALC)

Galactocerebrosidase; Krabbe Disease; Galactocerebroside beta-galactosidase; Galactosylceramidase; Galactosylceramide beta-galactosidase

  • Recombinant Galactosylceramidase (GALC) Packages (Simulation)
  • Recombinant Galactosylceramidase (GALC) Packages (Simulation)
  • RPG608Ra01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Galactosylceramidase (GALC)

USAGE of the Recombinant Galactosylceramidase (GALC)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Galactosylceramidase (GALC)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Galactosylceramidase (GALC)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Rattus norvegicus (Rat) Applications (RESEARCH USE ONLY!)
RPG608Ra01 Recombinant Galactosylceramidase (GALC) Positive Control; Immunogen; SDS-PAGE; WB.
PAG608Ra01 Polyclonal Antibody to Galactosylceramidase (GALC) WB; IHC; ICC; IP.
GUESTBOOK